2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
141
Breast Neoplasms
10
Neoplasm Metastasis
8
Neoplasms
5
Bulbo-Spinal Atrophy, X-Linked
5
Triple Negative Breast Neoplasms
4
Salivary Gland Neoplasms
3
Prostate Adenocarcinoma
2
Osteoporosis
2
Lower Urinary Tract Symptoms
2
Hirsutism
2
Thrombocytosis
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Stage I Prostate Adenocarcinoma
1
Sexual Dysfunction, Physiological
1
Recurrence
1
Primary Myelofibrosis
1
Primary Dysautonomias
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Paget Disease, Extramammary
1
PSA Level Greater Than Two
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Non Castrate Metastatic Prostate Cancer
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Interventions
bicalutamide
1
NVP-BKM120
1
Buserelin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non Castrate Metastatic Prostate Cancer
×
bicalutamide
×
Clear all
NCT02487823
2017-11-17
NCMPC-BKM
Institut Paoli-Calmettes
Phase 1
Terminated
6 enrolled